HIGHLIGHTS
- who: Stabilization et al. from the Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, China have published the article: Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization, in the Journal: Oxidative Medicine and Cellular Longevity of 10/08/2022
- what: This study was aimed at evaluating the inhibitory effects and potential mechanism of dapagliflozin (DAPA) against diabetic-related ferroptosis in the kidney. The authors sought to determine whether diabetes-related ferroptosis could be inhibited by DAPA, thereby . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.